Literature DB >> 1637026

Increased incidence of Hodgkin disease in homosexual men with HIV infection.

N A Hessol1, M H Katz, J Y Liu, S P Buchbinder, C J Rubino, S D Holmberg.   

Abstract

OBJECTIVE: To evaluate the incidence of Hodgkin disease and non-Hodgkin lymphoma among homosexual men infected with human immunodeficiency virus (HIV).
DESIGN: Cohort study with computer-matched identification of participants with the Northern California Cancer Center registry. Population rate comparisons were made with data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry. PARTICIPANTS: The 6704 homosexual men in the San Francisco City Clinic Cohort study. MEASUREMENTS: Incidence of Hodgkin disease, non-Hodgkin lymphoma, HIV infection, and the acquired immunodeficiency syndrome (AIDS); calculation of sex and age-adjusted standardized morbidity ratios and attributable risk.
RESULTS: Eight cases of Hodgkin disease and 90 cases of non-Hodgkin lymphoma were identified through computer matching among cohort members residing in the San Francisco Bay area from 1978 through 1989. Among the HIV-infected men, the age-adjusted standardized morbidity ratio was 5.0 (95% CI, 2.0 to 10.3) for Hodgkin disease and 37.7 (CI, 30.3 to 46.7) for non-Hodgkin lymphoma. The excess risk attributable to HIV infection was 19.3 cases of Hodgkin disease per 100,000 person-years and 224.9 cases of non-Hodgkin lymphoma per 100,000 person-years.
CONCLUSION: An excess incidence of Hodgkin disease was found in HIV-infected homosexual men. Additional well-designed epidemiologic studies are needed to determine whether Hodgkin disease should be considered an HIV-related malignancy.

Entities:  

Mesh:

Year:  1992        PMID: 1637026     DOI: 10.7326/0003-4819-117-4-309

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

Authors:  Robert J Biggar; Elaine S Jaffe; James J Goedert; Anil Chaturvedi; Ruth Pfeiffer; Eric A Engels
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

Review 2.  Hodgkin lymphoma.

Authors:  Joseph M Connors; Wendy Cozen; Christian Steidl; Antonino Carbone; Richard T Hoppe; Hans-Henning Flechtner; Nancy L Bartlett
Journal:  Nat Rev Dis Primers       Date:  2020-07-23       Impact factor: 52.329

3.  Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases.

Authors:  Meredith S Shiels; Erik H Koritzinsky; Christina A Clarke; Gita Suneja; Lindsay M Morton; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-10       Impact factor: 4.254

4.  Hodgkin's Disease in Patients with HIV Infection.

Authors:  Michele Spina; Antonino Carbone; Annunziata Gloghini; Diego Serraino; Massimiliano Berretta; Umberto Tirelli
Journal:  Adv Hematol       Date:  2010-09-23

Review 5.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

Review 6.  Evolving spectrum and incidence of non-AIDS-defining malignancies.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

7.  Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging Problem.

Authors:  Moosa Patel; Vinitha Philip; Fatima Fazel
Journal:  Adv Hematol       Date:  2011-02-08

8.  HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.

Authors:  Caron A Jacobson; Jeremy S Abramson
Journal:  Adv Hematol       Date:  2012-01-05

9.  The challenge of AIDS-related malignancies in sub-Saharan Africa.

Authors:  Annie J Sasco; Antoine Jaquet; Emilie Boidin; Didier K Ekouevi; Fabian Thouillot; Thomas Lemabec; Marie-Anna Forstin; Philippe Renaudier; Paul N'dom; Denis Malvy; François Dabis
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

10.  Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution.

Authors:  Marcelo Corti; Maria Villafañe; Gonzalo Minue; Ana Campitelli; Marina Narbaitz; Leonardo Gilardi
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.